BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI

BRISTOL MYERS SQUIBB CO

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$58.83−0.92 (-1.54%)

Close on Oct 19, 2026

Price history

Daily open, high, low, close and volume

Date	Open	High	Low	Close	Change	Volume
Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected.

From SEC filings

Date	Ratio	Effect on per-share figures
Mar 1, 1999	2-for-1	Earlier per-share figures divided by 2
Mar 3, 1997	2-for-1	Earlier per-share figures divided by 2
Jun 10, 1987	2-for-1	Earlier per-share figures divided by 2
May 27, 1983	2-for-1	Earlier per-share figures divided by 2
May 31, 1977	2-for-1	Earlier per-share figures divided by 2

Parsed from the XBRL in Bristol Myers Squibb's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Mar 1, 1999
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BMY.

Revenue growth3.1% · median 9.7%

Gross margin70.2% · median 71.5%

Net margin18.9% · median 9.8%

Advertisement
300 × 250